Skip to main content
. 2019 Feb 11;74(12):1916–1921. doi: 10.1093/gerona/glz045

Table 2.

Distributing of Comorbidities Among Community-Dwelling Older Adult U.S. Veterans

No Dementia (N = 716,841)
N (%)
Dementia (N = 13,385)
N (%)
Controls (N = 683,072) Meds (N = 33,769) All (N = 716,841) p Value* Controls (N = 6,847) Meds (N = 6,538) All (N = 13,385) p Value*
Cerebrovascular Disease 98,075 (14.4%) 2594 (7.7%) 100,669 (14%) <.001 2,776 (40.5%) 2140 (32.7%) 4,916 (36.7%) <.001
Heart Failure 45,770 (6.7%) 1138 (3.4%) 46,908 (6.5%) <.001 850 (12.4%) 552 (8.4%) 1,402 (10.5%) <.001
Chronic Kidney Disease 88,075 (12.9%) 2256 (6.7%) 90,331 (12.6%) <.001 1,391 (20.3%) 1087 (16.6%) 2,478 (18.5%) <.001
Connective Tissue Disease 378 (0.1%) 16 (0%) 394 (0.1%) .634 5 (0.1%) 3 (0%) 8 (0.1%) .671
Diabetes 418,985 (61.3%) 7,892 (23.4%) 426,877 (59.5%) <.001 3,105 (45.3%) 2,600 (39.8%) 5,705 (42.6%) <.001
Cancer 91,199 (13.4%) 1,962 (5.8%) 93,161 (13%) <.001 700 (10.2%) 646 (9.9%) 1,346 (10.1%) .483
Peptic Ulcer Disease 30,995 (4.5%) 830 (2.5%) 31,825 (4.4%) <.001 362 (5.3%) 300 (4.6%) 662 (4.9%) .178
Liver Disease 24,380 (3.6%) 728 (3.2%) 25,108 (3.5%) <.001 408 (6.0%) 307 (4.7%) 715 (5.3%) .011

*Fisher’s test, Significant difference (p < .05).